Join date: Nov 2, 2021

The global hemophilia treatment market is expected to accumulate considerable returns in the coming years due to the growing cases of genetic abnormalities as well as the prevalence of hemophilia. Hemophilia is a rare bleeding condition that leads to prolonged bleeding after an injury or a surgery owing to a delay in blood clotting. As per the World Federation of Hemophilia, the global prevalence of hemophilia stood at 184,723 in 2016. Rising efforts have been undertaken by the regulatory authorities across the globe to spread awareness regarding the disease and inform them about effective treatment solutions. As per a study, hemophilia treatment market size could cross USD 14.8 billion in terms of total remuneration through 2025.

More actions